Eagle Claw Capital Managment, LLC Bristol Myers Squibb CO Transaction History
Eagle Claw Capital Managment, LLC
- $666 Million
- Q3 2025
A detailed history of Eagle Claw Capital Managment, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 46,168 shares of BMY stock, worth $2.16 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
46,168
Previous 47,718
3.25%
Holding current value
$2.16 Million
Previous $2.21 Million
5.71%
% of portfolio
0.31%
Previous 0.35%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,717Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...